[36] With nearly 40% already demonstrating low bone mass before weight loss attempts, [3] and research showing BMD losses may not fully recover with weight regain, prevention becomes paramount
Patients and providers should be made aware of adverse CVEs in future studies, and pharmacologic and non-pharmacologic approaches should be examined to reduce NAFLD and adverse CVEs in individuals with type 2 diabetes
It stimulates GH release by binding to specific receptors in the body, which triggers the secretion of GH and increases appetite and fat metabolism
Dosage Contrave is indicated for long-term use, while phentermine is indicated for short-term use
In patients with early PD, the GLP-1RA lixisenatide can modestly slow the progression of motor dysfunction over 12 months of treatment, but it is associated with gastrointestinal side effects, and its long-term efficacy and safety require further verification (265)